• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Merit Medical slides to Q3 red on acquisition expenses

Merit Medical slides to Q3 red on acquisition expenses

October 27, 2017 By Brad Perriello

Merit MedicalExpenses from recent acquisitions pushed Merit Medical (NSDQ:MMSI) into the red during the third quarter, but the medical device maker still managed to top Wall Street’s earnings forecast for the quarter.

CEO Fred Lampropoulos said Merit acquired bone biopsy assets from Laurane Medical; spinal implant maker Osseon; steerable “smart” guidewire maker IntelliMedical Technologies; and ITL Healthcare and its custom procedure pack business.

South Jordan, Utah-based Merit posted losses of -$3.6 million, or -7¢ per share, on sales of $179.3 million for the three months ended Sept. 30, compared with profits of $973.0 million on sales growth of 14.2% during Q3 2016.

Adjusted to exclude one-time items, earnings per share were 32¢, 3¢ above the consensus expectation on The Street.

“Despite challenges with the general conditions of summer selling, the company delivered earnings above expectations which demonstrates both our commitment and discipline to our financial and operating plan, which, except as discussed below, we are confirming for the balance of this year, as well as our announced plans for 2018 and 2019,” Lampropoulos said in prepared remarks.

The slide into red ink was due to $12.1 million spent on patents and a $778,000 reduction from the buyout of Argon Medical Devices earlier this year, Merit said.

The company said it’s lowering its full-year EPS forecast for the rest of the year on an R&D charge stemming from the IntelliMedical deal to 55¢ to 61¢, down from 80¢ to 86¢ previously. Adjusted EPS, however, are still pegged at $1.23 to $1.28 on sales of of $722 million to $727 million.

MMSI shares are off -11.5% to $36.90 apiece since the Oct. 25 earnings release.

Filed Under: MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: Merit Medical Systems

More recent news

  • Medtronic partners with IRCAD on Hugo, Affera surgical training
  • 23andMe co-founder wins bid to take back control of company
  • Neurent Medical opens new manufacturing facility in Ireland
  • Brain Navi wins FDA nod for neurosurgical robot
  • Adona Medical completes enrollment in first-in-human interatrial shunt trial

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy